Background:  ATRX is a member of the SNF2 family of helicase/ATPases, which contribute to the remodeling of the nucelosome structure in an ATP-dependent manner, and facilitate the initiation of transcription and replication. Structurally, ATRX contains a PHD zinc finger motif. ATRX is regulated throughout the cell cycle where it is differentially distributed within the nucleus. During interphase, ATRX predominately associates with the nuclear matrix, while during mitosis, ATRX localizes with condensed chromatin. At the onset of M phase, phosphorylation rapidly induces this redistribution of ATRX to the short arms of human acrocentric chromosomes, where it then specifically complexes with heterochromatin protein 1 å to mediate chromosomal segregation. Mutations in the ATRX gene correlate with a high incidence of severe X-linked form of syndromal mental retardation associated with å thalassaemia or ATR-X syndrome.

Description: Rabbit polyclonal to ATRX

Immunogen: KLH conjugated synthetic peptide derived from ATRX

Specificity:  ·Reacts with Human, Mouse and Rat.

·Isotype: IgG

Application:  ·Western blotting: 1/200-500. Predicted Mol wt: 283 kDa;

·Immunohistochemistry (Frozen/paraffin tissue section): 1/50-100;

·Immunocytochemistry: 1/100;

·Optimal working dilutions must be determined by the end user.